About: Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on September 2016

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2016 (ast) наукова стаття, опублікована у вересні 2016 (uk) مقالة علمية نشرت في سبتمبر 2016 (ar) scientific article published on September 2016 (en)
publication date	wds:Q37257019-EF1B99B1-911F-4454-9A6F-0909FA30C1DF
publication date	2016-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37257019-01F74B3A-9363-4711-879B-C580A7F3BFE4
language of work or name	English
cites work	wds:Q37257019-0192A08A-F6B7-4EC9-A000-20E0097E1E08 wds:Q37257019-19C44CAA-D5D9-46C4-8D9D-2C6F243689D5 wds:Q37257019-1BC1C33D-73D6-4131-9A96-2D8FE761A6F0 wds:Q37257019-38EE34E7-599C-4598-8ACE-495BBFFF3840 wds:Q37257019-4AF95EEB-C27F-4BA7-9219-17836ADD25E3 wds:Q37257019-4C95432E-0481-473C-AD32-5165F578C821 wds:Q37257019-512A6443-FC93-4D8C-A37D-94572A4DCA02 wds:Q37257019-540BCB05-1ED1-45A2-92B1-7BB151A20AAF wds:Q37257019-59CB533C-8B72-4F36-B890-0F08E00A4300 wds:Q37257019-6560B0C8-45DC-450F-8ABD-32B641D489EE wds:Q37257019-8E5EA56A-5A67-494B-9D3D-4655C8B6A34D wds:Q37257019-9249343E-1320-4CBA-8522-C058A3820F8A wds:Q37257019-A6374252-4655-4359-900D-F5E8B1357413 wds:Q37257019-A88FC8A7-680B-40BB-95E3-B55C2672F593 wds:Q37257019-AF855617-567E-44EE-8C32-A70E77000663 wds:Q37257019-CCE72C79-58AD-40B6-A780-4287450EFB0D wds:Q37257019-E3814642-FAD9-443A-A75B-375FF9EC10B6 wds:Q37257019-EC0EE4BE-5101-4296-831C-DB283C130DB5 wds:Q37257019-EC213C1B-D55D-4BC6-818F-02585E764336 wds:Q37257019-F955FF25-E972-4E79-AAF3-1F5731BE0EA4
cites work	Ovarian cancer: a focus on management of recurrent disease Cancer statistics, 2015 A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer "Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit? Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas. Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges? Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer Adjuvant chemotherapy TP53 K351N mutation-associated platinum resistance after neoadjuvant chemotherapy in patients with advanced ovarian cancer
author name string	wds:Q37257019-083B57A2-BB98-41F5-9538-C5641AC7F33D wds:Q37257019-221739E1-BD71-4746-A75E-C0093EE8B84B wds:Q37257019-717D90B4-EB5F-465E-B6C4-562A6C702B4E wds:Q37257019-E77FFC40-5F81-4135-8CE5-912B02A850F3
author name string	Yong Sang Song Hee Seung Kim Hyun Hoon Chung Yanlin Luo
rdfs:label	Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (en) Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (nl) Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (ast)
skos:prefLabel	Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (en) Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (nl) Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (ast)
name	Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (en) Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (nl) Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (ast)
author	wds:Q37257019-D034C30B-68C8-4D1C-849C-AE2E902EB5AD
author	Maria Lee
title	wds:Q37257019-B97D5DE4-95E4-4E30-A691-FD3591CB4535
title	Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer (en)
page(s)	wds:Q37257019-6ABCE187-D52E-4085-B966-F7B80CC5EF69
page(s)	e4797
instance of	wds:Q37257019-96691E7A-479D-45D6-B22F-EC976CEFC7C3
instance of	scholarly article
main subject	wds:Q37257019-80538EC3-3ABA-4A87-A232-3A69E8212FCC wds:Q37257019-88ED43A0-CA11-43D5-959F-7F11FFE5900D wds:Q37257019-C9BD2A4D-63AC-46E3-856F-EBA83433A5AD wds:Q37257019-E063CF3B-27D7-4DB1-B8E8-8350F8156425
main subject	ovarian neoplasm platinum chemotherapy neoadjuvant chemotherapy
PubMed ID	wds:Q37257019-CAB80D1C-90EB-441A-BA9B-BD29AB6ABB25
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27603388
PubMed ID	27603388
published in	wds:Q37257019-0658C264-77D2-49F3-877E-E52BA04BE3F2
published in	Medicine (Barcelona) / Programa de Educación Médica Continuada (EMC) en medicina Asistencial
issue	wds:Q37257019-43C34368-AA17-41AE-B152-62DA8E91CA95

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software